Synthetic disialylgalactose immunoadsorbents deplete anti-GQ1b antibodies from autoimmune neuropathy sera.
D000818:Animals; D000911:Antibodies, Monoclonal / Q000276:immunology / Q000302:isolation & purification; D000937:Antigen-Antibody Reactions; D005732:Gangliosides / Q000097:blood* / Q000276:immunology; D006017:Glycolipids / Q000276:immunology; D020275:Guillain-Barre Syndrome / Q000276:immunology*; D006801:Humans; D007074:Immunoglobulin G / Q000276:immunology; D007075:Immunoglobulin M / Q000276:immunology; D007163:Immunosorbent Techniques; D007164:Immunosorbents / Q000494:pharmacology*; D051379:Mice; D008815:Mice, Inbred Strains; D018345:Mice, Knockout
D000911:Antibodies, Monoclonal; D005732:Gangliosides; D006017:Glycolipids; D007074:Immunoglobulin G; D007075:Immunoglobulin M; D007164:Immunosorbents; C026226:ganglioside, GD3; C039129:GQ1b ganglioside